Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Abbot Stock Was a Winner Today

TheMotleyFool

0 0

Abbott Laboratories (NYSE: ABT) ended up outpacing the broader stock market on Thursday, with its share price rising by more than 2% against the 0.7% bump of the S&P 500 index. Investors were clearly happy with the latest product news from the company.

Abbott reported some highly encouraging data about its Amplatzer Piccolo Occluder, a device that treats a common congenital heart defect in infants called patent ductus arteriosus (PDA).

According to the big healthcare company, the three years of data it has compiled on the device indicate that it produced a survival rate of nearly 96%, with zero procedure-related deaths. The implant success rate was similar, and the device closed the PDA in nearly every patient.

Source Fool.com

Like: 0

ABT

Share